228 related articles for article (PubMed ID: 26892448)
1. Anticoagulation, CHA2DS2VASc Score, and Thromboembolic Risk of Cardioversion of Acute Atrial Fibrillation (from the FinCV Study).
Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Ylitalo A; Airaksinen KE
Am J Cardiol; 2016 Apr; 117(8):1294-8. PubMed ID: 26892448
[TBL] [Abstract][Full Text] [Related]
2. Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study.
Airaksinen KE; Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Biancari F; Hartikainen JE
J Am Coll Cardiol; 2013 Sep; 62(13):1187-92. PubMed ID: 23850908
[TBL] [Abstract][Full Text] [Related]
3. Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study.
Bah A; Nuotio I; Grönberg T; Ylitalo A; Airaksinen KE; Hartikainen JE
Ann Med; 2017 May; 49(3):254-259. PubMed ID: 28042730
[TBL] [Abstract][Full Text] [Related]
4. Safety of cardioversion in atrial fibrillation lasting less than 48 h without post-procedural anticoagulation in patients at low cardioembolic risk.
Tampieri A; Cipriano V; Mucci F; Rusconi AM; Lenzi T; Cenni P
Intern Emerg Med; 2018 Jan; 13(1):87-93. PubMed ID: 28025766
[TBL] [Abstract][Full Text] [Related]
5. [Electrical cardioversion for non-valvular atrial fibrillation--underestimated risk for thromboembolic complications?].
Klein HH
Dtsch Med Wochenschr; 2013 Jun; 138(24):1309-11. PubMed ID: 23737116
[TBL] [Abstract][Full Text] [Related]
6. Safety of electrical cardioversion in patients with atrial fibrillation.
Gentile F; Elhendy A; Khandheria BK; Seward JB; Lohse CM; Shen WK; Bailey KR; Montgomery SC; Burger KN; Tajik AJ
Mayo Clin Proc; 2002 Sep; 77(9):897-904. PubMed ID: 12233921
[TBL] [Abstract][Full Text] [Related]
7. Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study.
Grönberg T; Nuotio I; Nikkinen M; Ylitalo A; Vasankari T; Hartikainen JE; Airaksinen KE
Europace; 2013 Oct; 15(10):1432-5. PubMed ID: 23687124
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation).
Flaker G; Lopes RD; Al-Khatib SM; Hermosillo AG; Hohnloser SH; Tinga B; Zhu J; Mohan P; Garcia D; Bartunek J; Vinereanu D; Husted S; Harjola VP; Rosenqvist M; Alexander JH; Granger CB;
J Am Coll Cardiol; 2014 Mar; 63(11):1082-7. PubMed ID: 24211508
[TBL] [Abstract][Full Text] [Related]
9. Intensity of anticoagulation and risk of thromboembolism after elective cardioversion of atrial fibrillation.
Hellman T; Kiviniemi T; Nuotio I; Vasankari T; Hartikainen J; Lip GYH; Airaksinen KEJ
Thromb Res; 2017 Aug; 156():163-167. PubMed ID: 28662483
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation patients with CHA2DS2-VASc >1 benefit from oral anticoagulation prior to cardioversion.
Själander S; Svensson PJ; Friberg L
Int J Cardiol; 2016 Jul; 215():360-3. PubMed ID: 27128562
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
12. Safety of electrical cardioversion in patients with previous embolic events.
Elhendy A; Gentile F; Khandheria BK; Bailey KR; Burger KN; Seward JB
Mayo Clin Proc; 2001 Apr; 76(4):364-8. PubMed ID: 11322351
[TBL] [Abstract][Full Text] [Related]
13. Cardioversion for atrial fibrillation - how to prevent thromboembolic complications?
Jaakkola S; Kiviniemi TO; Airaksinen KEJ
Ann Med; 2018 Nov; 50(7):549-555. PubMed ID: 30207497
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation for cardioversion of atrial fibrillation.
El Gendi H; Ismail T; Charalampos K; Mayet J
Minerva Cardioangiol; 2002 Feb; 50(1):43-52. PubMed ID: 11830718
[TBL] [Abstract][Full Text] [Related]
15. Strokes after cardioversion of atrial fibrillation--The FibStroke study.
Palomäki A; Mustonen P; Hartikainen JE; Nuotio I; Kiviniemi T; Ylitalo A; Hartikainen P; Lehtola H; Luite R; Airaksinen KE
Int J Cardiol; 2016 Jan; 203():269-73. PubMed ID: 26519683
[TBL] [Abstract][Full Text] [Related]
16. Thromboembolic and bleeding complications after elective cardioversion of atrial fibrillation: a nationwide cohort study.
Itäinen-Strömberg S; Lehto M; Halminen O; Putaala J; Haukka J; Lehtonen O; Teppo K; Mustonen P; Linna M; Hartikainen J; Airaksinen KEJ; Aro AL
Europace; 2024 Jun; 26(6):. PubMed ID: 38829189
[TBL] [Abstract][Full Text] [Related]
17. Prevention of embolic events after cardioversion of atrial fibrillation. Current and evolving strategies.
Kinch JW; Davidoff R
Arch Intern Med; 1995 Jul; 155(13):1353-60. PubMed ID: 7794083
[TBL] [Abstract][Full Text] [Related]
18. Can we predict the failure of electrical cardioversion of acute atrial fibrillation? The FinCV study.
Grönberg T; Hartikainen JE; Nuotio I; Biancari F; Vasankari T; Nikkinen M; Ylitalo A; Airaksinen KE
Pacing Clin Electrophysiol; 2015 Mar; 38(3):368-75. PubMed ID: 25534241
[TBL] [Abstract][Full Text] [Related]
19. Ventricular rate during acute atrial fibrillation and outcome of electrical cardioversion: The FinCV Study.
Jaakkola J; Hartikainen JE; Kiviniemi T; Nuotio I; Nammas W; Grönberg T; Karmi A; Ylitalo A; Airaksinen KE
Ann Med; 2015 Jun; 47(4):341-5. PubMed ID: 25943162
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic complications after electrical cardioversion in patients with atrial flutter.
Elhendy A; Gentile F; Khandheria BK; Gersh BJ; Bailey KR; Montgomery SC; Seward JB; Tajik AJ
Am J Med; 2001 Oct; 111(6):433-8. PubMed ID: 11690567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
